ChromaDex To Host Key Opinion Leader Webinar on the Transforming Benefits of Nicotinamide Riboside (NR)

LOS ANGELES–(BUSINESS WIRE)—- $CDXC #DrCharlesBrenner–ChromaDex Corp. (NASDAQ:CDXC) today announced that it will host a key opinion leader (KOL) webinar on the transforming benefits of nicotinamide riboside (NR) on Wednesday, July 20, 2022 at 11:00 am Eastern Time. The webinar will feature a presentation from KOL and discoverer of the vitamin…